195 related articles for article (PubMed ID: 25351623)
1. COBAS ® AmpliPrep/COBAS ® Taqman ® HCV Quantitative Test, version 2.0: an in vitro test for hepatitis C virus RNA quantification.
Deeks ED
Mol Diagn Ther; 2015 Feb; 19(1):1-7. PubMed ID: 25351623
[TBL] [Abstract][Full Text] [Related]
2. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system.
Sizmann D; Boeck C; Boelter J; Fischer D; Miethke M; Nicolaus S; Zadak M; Babiel R
J Clin Virol; 2007 Apr; 38(4):326-33. PubMed ID: 17344093
[TBL] [Abstract][Full Text] [Related]
3. HCV RNA detection in HCV antibody-positive patients with the COBAS AmpliPrep/COBAS TaqMan HCV test, v2.0 in comparison with FDA-approved nucleic acid tests.
Butcher A; Aslam S; Hemyari P; Cowen U; Heilek G
J Clin Virol; 2014 Aug; 60(4):336-40. PubMed ID: 24881014
[TBL] [Abstract][Full Text] [Related]
4. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
Pyne MT; Mallory M; Hillyard DR
J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the QIAGEN artus HCV QS-RGQ test with the Roche COBAS Ampliprep/COBAS TaqMan HCV test v2.0 for the quantification of HCV-RNA in plasma samples.
Schønning K
J Clin Virol; 2014 Aug; 60(4):323-7. PubMed ID: 24894603
[TBL] [Abstract][Full Text] [Related]
7. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
[TBL] [Abstract][Full Text] [Related]
8. Second-generation Cobas AmpliPrep/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design.
Zitzer H; Heilek G; Truchon K; Susser S; Vermehren J; Sizmann D; Cobb B; Sarrazin C
J Clin Microbiol; 2013 Feb; 51(2):571-7. PubMed ID: 23241371
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
[TBL] [Abstract][Full Text] [Related]
10. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument.
Germer JJ; Harmsen WS; Mandrekar JN; Mitchell PS; Yao JD
J Clin Microbiol; 2005 Jan; 43(1):293-8. PubMed ID: 15634985
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
[TBL] [Abstract][Full Text] [Related]
13. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay.
Kinai E; Hanabusa H; Kato S
J Med Virol; 2007 Aug; 79(8):1113-9. PubMed ID: 17596840
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of the Artus hepatitis C virus QS-RGQ assay.
Paba P; Fabeni L; Perno CF; Ciotti M
J Virol Methods; 2012 Jan; 179(1):77-80. PubMed ID: 22001273
[TBL] [Abstract][Full Text] [Related]
17. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
[TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
[TBL] [Abstract][Full Text] [Related]
19. Improved COBAS TaqMan hepatitis C virus test (Version 2.0) for use with the High Pure system: enhanced genotype inclusivity and performance characteristics in a multisite study.
Colucci G; Ferguson J; Harkleroad C; Lee S; Romo D; Soviero S; Thompson J; Velez M; Wang A; Miyahara Y; Young S; Sarrazin C
J Clin Microbiol; 2007 Nov; 45(11):3595-600. PubMed ID: 17898157
[TBL] [Abstract][Full Text] [Related]
20. Quantification of hepatitis C virus in patients treated with peginterferon-alfa 2a plus ribavirin treatment by COBAS TaqMan HCV test.
Kanda T; Imazeki F; Yonemitsu Y; Mikami S; Takada N; Nishino T; Takashi M; Tsubota A; Kato K; Sugiura N; Tawada A; Wu S; Tanaka T; Nakamoto S; Mikata R; Tada M; Chiba T; Kurihara T; Arai M; Fujiwara K; Kanai F; Yokosuka O
J Viral Hepat; 2011 Jul; 18(7):e292-7. PubMed ID: 21129130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
